Pharma

Your Article Summary

See Latest Articles

Labopharm receives approvable letter from FDA for once-daily tramadol
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/02/06

Labopharm Inc. announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for its once-daily formulation of tramadol. In its letter, the FDA indicated that Labopharm's once-daily formulation of tramadol is approvable subject to the resolution of certain issues

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09

 See all of Drug/Product Approvals